Media Kit
Includes our Foundation Backgrounder, general information on Prostate Cancer, and much more.
Contact Us
For Additional Information send an email to press@pcf.org or call (310) 570-4722
Brand Identity
To reference PCF for any of your communications, get the approved logos, language, and messaging.
Featured Coverage
Atlanta Hawks, Prostate Cancer Foundation Team Up To Fight Prostate Cancer
ATLANTA – The Atlanta Hawks and Prostate Cancer Foundation (PCF) have joined together to launch a first-of-its-kind multi-pronged program with the goal of slamming prostate cancer. Led by Hawks Vice Chair of the Board and Naismith Memorial Basketball Hall...
Read More
Fuego Box Turns Up The Heat On Prostate Cancer With The Choco Challenge™
LOS ANGELES - JANUARY 31, 2019 As Valentine’s Day approaches, spice up your life while supporting the fight against prostate cancer. Fuego Box, purveyors of small-batch/craft hot sauces delivered to your door monthly, is teaming up with...
Read MoreBREAKING NEWS: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer
September 18, 2019 – Last night the U.S. Food and Drug Administration (FDA) approved apalutamide...
The Prostate Cancer Foundation Made History by Lighting U.S. Landmarks “Blue” Across All 50 States to Illuminate Prostate Cancer Issue
LOS ANGELES, Calif., September 4, 2019 – For the first time in American history, U.S....
Researchers Discover How a Gene Deletion Contributes to Prostate Cancer Growth
Original Press Release Issued by: Weill Cornell Medicine The deletion of a gene that normally...
Andrea K. Miyahira, PhD
New Study Identifies Another Opportunity for Precision Immunotherapy in Prostate Cancer
A new Prostate Cancer Foundation (PCF)-funded study published today in the scientific journal Cell has...
The Prostate Cancer Foundation and the Movember Foundation Announce 2019 Challenge Award Winners
The Prostate Cancer Foundation (PCF) and the Movember Foundation today announced three new Movember Foundation-PCF...
Gene test picks out prostate cancer patients who could benefit from ‘search-and-destroy’ medicine
Original Press Release Issued by: The Institute of Cancer Research, London Testing for genetic weaknesses...
The Prostate Cancer Foundation Made History by Lighting U.S. Landmarks “Blue” Across All 50 States to Illuminate Prostate Cancer Issue
LOS ANGELES, Calif., September 4, 2019 – For the first time in American history, U.S....
FDA Approves Bayer's Nubeqa® (darolutamide), a New Treatment for Men with Non-Metastatic Castration-Resistant Prostate Cancer
WHIPPANY, N.J., July 30, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today...
Brand Identity
To reference PCF for any of your communications, get the approved logos and language